DE60302287D1 - Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen - Google Patents

Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen

Info

Publication number
DE60302287D1
DE60302287D1 DE60302287T DE60302287T DE60302287D1 DE 60302287 D1 DE60302287 D1 DE 60302287D1 DE 60302287 T DE60302287 T DE 60302287T DE 60302287 T DE60302287 T DE 60302287T DE 60302287 D1 DE60302287 D1 DE 60302287D1
Authority
DE
Germany
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60302287T
Other languages
English (en)
Other versions
DE60302287T2 (de
Inventor
Thierry Dubuffet
Jean-Pierre Lecouve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of DE60302287D1 publication Critical patent/DE60302287D1/de
Publication of DE60302287T2 publication Critical patent/DE60302287T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60302287T 2003-08-29 2003-08-29 Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen Expired - Lifetime DE60302287T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03292132A EP1380591B1 (de) 2003-08-29 2003-08-29 Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen

Publications (2)

Publication Number Publication Date
DE60302287D1 true DE60302287D1 (de) 2005-12-22
DE60302287T2 DE60302287T2 (de) 2006-08-10

Family

ID=29724624

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60302287T Expired - Lifetime DE60302287T2 (de) 2003-08-29 2003-08-29 Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen

Country Status (18)

Country Link
US (1) US7534896B2 (de)
EP (1) EP1380591B1 (de)
JP (1) JP4331206B2 (de)
CN (1) CN100383160C (de)
AR (1) AR045516A1 (de)
AT (1) ATE310012T1 (de)
AU (1) AU2004270428B2 (de)
DE (1) DE60302287T2 (de)
DK (1) DK1380591T3 (de)
EA (1) EA008668B1 (de)
ES (1) ES2252633T3 (de)
HK (1) HK1096408A1 (de)
MY (1) MY136638A (de)
NZ (1) NZ545336A (de)
PL (1) PL211508B1 (de)
SI (1) SI1380591T1 (de)
WO (1) WO2005023842A1 (de)
ZA (1) ZA200601429B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1371659T3 (da) * 2003-08-29 2005-11-21 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
EP1679072B9 (de) 2005-01-06 2009-09-02 IPCA Laboratories Limited Verfahren zur Synthese von (2S,3aS,7aS)-1-(S)-Alanyl-octahydro-1H-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril
DK2318365T3 (en) 2008-06-24 2015-11-23 Mylan Lab Ltd NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
JP6753699B2 (ja) * 2016-05-27 2020-09-09 ミネベアミツミ株式会社 転がり軸受

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1321471B1 (de) 2003-03-12 2005-05-04 Les Laboratoires Servier Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
ES2231759T3 (es) * 2003-03-12 2005-05-16 Les Laboratoires Servier Procedimiento para la sintesis de derivados de acido (2s,3as,7as)-1-(s)-alanil)-octahidro-1h-indol-2-carboxilico y su utilizacion en la sintesis de perindopril.
ATE315043T1 (de) * 2003-06-30 2006-02-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
ES2272922T3 (es) * 2003-08-29 2007-05-01 Les Laboratoires Servier Nuevo procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables.
DK1371659T3 (da) * 2003-08-29 2005-11-21 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1420028T3 (da) * 2003-11-19 2007-06-18 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Also Published As

Publication number Publication date
ES2252633T3 (es) 2006-05-16
SI1380591T1 (sl) 2006-02-28
PL211508B1 (pl) 2012-05-31
DE60302287T2 (de) 2006-08-10
JP2007526902A (ja) 2007-09-20
DK1380591T3 (da) 2006-01-23
AU2004270428A1 (en) 2005-03-17
WO2005023842A1 (fr) 2005-03-17
EA008668B1 (ru) 2007-06-29
ATE310012T1 (de) 2005-12-15
JP4331206B2 (ja) 2009-09-16
EA200600454A1 (ru) 2006-08-25
US7534896B2 (en) 2009-05-19
HK1096408A1 (en) 2007-06-01
NZ545336A (en) 2009-03-31
AR045516A1 (es) 2005-11-02
AU2004270428B2 (en) 2008-08-21
US20070010572A1 (en) 2007-01-11
EP1380591B1 (de) 2005-11-16
CN1835966A (zh) 2006-09-20
EP1380591A1 (de) 2004-01-14
ZA200601429B (en) 2007-05-30
MY136638A (en) 2008-11-28
PL379628A1 (pl) 2006-10-30
CN100383160C (zh) 2008-04-23

Similar Documents

Publication Publication Date Title
DE60129800D1 (de) Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze
NO20050741D0 (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
FR2868414B1 (fr) Procede de production d'alpha-alumine particulaire et apha-alumine particulaire produite par ce procede
NO20054317D0 (no) Fremgangsmate for homogenisering av polyolefin-DRA-midler
HK1089187A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
EG24152A (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
DE60311942D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60303101D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
HK1096409A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
ATE365714T1 (de) Verfahren zur herstellung von hochreinem perindopril und zwischenverbindungen nützlich in der synthese
DE60300581D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60301820D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
HK1096408A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
DE60319196D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE60301930D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salze
DE60311730D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE60307721D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60307925D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60336931D1 (de) Verfahren zur synthese der bisbenzimidazolen und ihren derivaten.
DE60300068D1 (de) Metallschaum und Verfahren zu seiner Herstellung
FR2861727B1 (fr) Procede de synthese directe d'alkylhalogenosilanes
FR2844792B1 (fr) Procede de synthese du 2-chloropropionitrile

Legal Events

Date Code Title Description
8364 No opposition during term of opposition